Target intelligence / Profile preview

CD200 like, pseudogene (CD200LP)

Target
CD200LP
Molecular classification
Other
01

Overview

CD200 like, pseudogene (CD200LP) is annotated as a pseudogene, which means it is a genomic DNA sequence similar to the functional CD200 gene but lacks the capacity to encode a protein or serve any known biological or therapeutic function. Pseudogenes are typically non-functional remnants of genes that may arise due to gene duplication or retrotransposition events, and they do not have roles as drug targets or molecular receptors[4]. CD200LP should not be confused with CD200 (also known as OX-2), which is a bona fide membrane glycoprotein receptor involved in immune regulation[1][2][3]. CD200LP does not fall into any classical molecular classification associated with druggable targets (such as receptor, enzyme, transporter, or transcription factor). No drugs, biomarkers, or disease roles are associated with this pseudogene. If you are seeking information about immunoregulatory targets related to the CD200 family, you likely want "CD200 (OX-2 membrane glycoprotein)" or "CD200 receptor."

Other names
CD200L pseudogene

Beyond the preview

Go deeper on CD200 like, pseudogene (CD200LP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CD200 like, pseudogene (CD200LP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call